Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96PY6: Variant p.Ser155Thr

Serine/threonine-protein kinase Nek1
Gene: NEK1
Feedback?
Variant information Variant position: help 155 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Serine (S) to Threonine (T) at position 155 (S155T, p.Ser155Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In OFD2; uncertain significance; the nucleotide substitution creating this missense variant may predominantly result in aberrant splicing, with skipping of exon 6 and creation of a premature stop codon, possibly leading to nonsense-mediated mRNA decay. Any additional useful information about the variant.


Sequence information Variant position: help 155 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1258 The length of the canonical sequence.
Location on the sequence: help FLTKDGTVQLGDFGIARVLN S TVELARTCIGTPYYLSPEIC The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1258 Serine/threonine-protein kinase Nek1
Domain 4 – 258 Protein kinase
Modified residue 156 – 156 Phosphothreonine
Modified residue 162 – 162 Phosphothreonine; by autocatalysis
Helix 155 – 164



Literature citations
Compound heterozygous NEK1 variants in two siblings with oral-facial-digital syndrome type II (Mohr syndrome).
Monroe G.R.; Kappen I.F.; Stokman M.F.; Terhal P.A.; van den Boogaard M.H.; Savelberg S.M.; van der Veken L.T.; van Es R.J.; Lens S.M.; Hengeveld R.C.; Creton M.A.; Janssen N.G.; Mink van der Molen A.B.; Ebbeling M.B.; Giles R.H.; Knoers N.V.; van Haaften G.;
Eur. J. Hum. Genet. 24:1752-1760(2016)
Cited for: INVOLVEMENT IN OFD2; VARIANTS OFD2 THR-155 AND 409-TRP--GLU-1258 DEL;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.